4C9W |
Crystal structure of NUDT1 (MTH1) with R-crizotinib |
date |
|
authors | Elkins, J.M., Salah, E., Huber, K., Superti-Furga, G., Azeez, K.R.Abdul., Raynor, J., Krojer, T., Delft, F.von., Bountra, C., Edwards, A., Knapp, S. |
compound |
source |
symmetry | |
|
crystal cell |
length a |
length b |
length c |
angle alpha |
angle beta |
angle gamma |
|
|
|
|
|
|
|
method | X-Ray Diffraction | resolution | 1.65 |
ligand | CL, SO4, VGH
| enzyme |
|
Gene Ontology |
Chain | Function | Process | Component | A |
|
|
|
|
Primary reference | Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy., Huber KV, Salah E, Radic B, Gridling M, Elkins JM, Stukalov A, Jemth AS, Gokturk C, Sanjiv K, Stromberg K, Pham T, Berglund UW, Colinge J, Bennett KL, Loizou JI, Helleday T, Knapp S, Superti-Furga G, Nature. 2014 Apr 10;508(7495):222-7. doi: 10.1038/nature13194. Epub 2014 Apr 2. PMID:24695225 |